Twilight Bioscience, Inc.
Publicly observedTopsfield, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Topsfield | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Twilight Bioscience, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | YTMPKL72Y4H7 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant24 Sept 2026Publicly observed
NIH SBIR/STTR award: Development of an Anti-Nerve Growth Factor Active Immunotherapy for Difficult-to-Manage Pain
USD 350,188.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant22 Sept 2026Publicly observed
NIH SBIR/STTR award: A HERV-K (HML-2) Immunization Strategy for the Treatment and Prevention of Amyotrophic Lateral Sclerosis
USD 497,416.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.